| Trial Identifier: | 4464-001 |
| Sponsor: | MSD |
| Start Date: | September 2022 |
| Primary Completion Date: | March 2026 |
| Study Completion Date: | March 2026 |
| Condition: | Cancer - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| Protocol Plain Language Summary- English |
| Country | Location |
|---|---|
| Canada, ON | Toronto, ON, Canada, M5G 2M9 |
| Israel, N/A | Haifa, N/A, Israel, 3109601 |
| Israel, N/A | Jerusalem, N/A, Israel, 9112001 |
| Netherlands, Noord-Holland | Amsterdam, Noord-Holland, Netherlands, 1081HV |
| Netherlands, Noord-Holland | Amsterdam, Noord-Holland, Netherlands, 1066CX |
| United States, KY | Louisville, KY, United States, 40245 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2026 Pharma Intelligence UK Limited (Citeline), a Norstella company